Study finds sharp increase in mental health admissions among children in England

There was a 65% increase in the number of children and young people being admitted to general acute medical wards in hospitals in England because of a mental health concern between 2012 and 2022, finds a new study led by UCL researchers.

FDA OKs Mirdametinib for Neurofibromatosis Type 1

The FDA on Tuesday approved mirdametinib (Gomekli) for adults and kids ages 2 and up with neurofibromatosis type 1 (NF1). Approval of the MEK inhibitor

February 12, 2025

Conduit acquires three first-in-class assets from AstraZeneca – Pharmaceutical Technology

Conduit has acquired two HK-4 glucokinase activators—AZD1656 and AZD5658, and AZD5904, a myeloperoxidase inhibitor (MPO). Credit: PeopleImages.com – Yuri A via Shutterstock. Conduit Pharmaceuticals’ will

August 8, 2024

Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy

In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines,

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.